Jerusalem Post: Israeli co. kicks off COVID oral vaccine trial in South Africa
The first volunteer in a Phase I clinical trial of an oral COVID-19 vaccine developed by an Israeli-American company has been screened and enrolled, according to Oravax Medical, a subsidiary of Oramed Pharmaceuticals. The trial is taking place in South Africa. Read more here.
